Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Stomach Neoplasms 11Esophageal Neoplasms 8Barrett Esophagus 6Gastrointestinal Neoplasms 5Rectal Neoplasms 3Colonic Neoplasms 3Precancerous Conditions 2Lung Neoplasms 2Hemorrhage 2Gastric GIST 2Esophageal Squamous Cell Carcinoma 2Colonic Polyps 2Carcinoma, Non-Small-Cell Lung 2Adenoma 2Adenocarcinoma Of Esophagus 2Tobacco Use Disorder 1Submucosal Tumor of Stomach 1Small Size Gastrointestinal Stromal Tumors 1Small Cell Lung Carcinoma 1Rectal Neuroendocrine Tumors 1Polyps 1Pituitary Neoplasms 1Personal Satisfaction 1Pathological Conditions, Anatomical 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Glandular and Epithelial 1

Interventions

Gemcitabine 677130-nm albumin-bound paclitaxel 197Fluorouracil 184Oxaliplatin 173Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 129Irinotecan 111Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 71Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 48Magnetic Resonance Spectroscopy 45folfirinox 42Docetaxel 41Cetuximab 40irinotecan sucrosofate 36Specimen Handling 36S 1 (combination) 36Biopsy 30Radiation 29Paclitaxel 29Ipilimumab 27Surgical Procedures, Operative 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Endoscopic Mucosal Resection × Clear all
NCT00602602 2020-04-27

Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
19 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡